Literature DB >> 18486534

Genetic association of cytokine DNA polymorphisms with head and neck cancer.

Zoe Serefoglou1, Christos Yapijakis, Emeka Nkenke, Eleftherios Vairaktaris.   

Abstract

Mutations in oncogenes or tumor suppressor genes, as well as environmental factors such as tobacco chewing or smoking, poor oral hygiene, ill-fitting dental appliances, infection by certain HPV types, or alcohol abuse, seem to be involved in the multifactorial process of carcinogenesis in head and neck. Recently, several genetic association studies have indicated that common DNA polymorphisms in low penetrance genes may affect the susceptibility of an individual to malignancy. Cytokines are an important group of proteins that regulate and mediate inflammation and angiogenesis. Tumor growth, invasion and metastasis are facilitated when there is a deregulation in their production. Cytokines include interleukins (ILs), tumor necrosis factors (TNFs) and certain growth factors (GFs). A number of genetic association studies have recently investigated the putative correlation between functional DNA polymorphisms in cytokine genes and head and neck carcinomas. This review discusses the findings of such studies in oral, nasopharyngeal and esophageal squamous cell carcinomas. Extensive research has indicated that functional polymorphisms affecting gene expression of IL-4,-6,-8,-10 as well as TNF-alpha are strongly associated with increased risk for oral cancer. Gene expression of TNF-alpha seems to be associated also with esophageal carcinomas, while for nasopharyngeal cancer the picture is yet unclear. It is generally believed that such genetic association studies will gradually increase our knowledge regarding the predisposed manifestation and advancement of these malignancies in the head and neck region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486534     DOI: 10.1016/j.oraloncology.2008.02.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  22 in total

1.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

2.  Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men.

Authors:  Satoru Sugie; Hiromasa Tsukino; Shoichiro Mukai; Takahiro Akioka; Norihiko Shibata; Masafumi Nagano; Toshiyuki Kamoto
Journal:  Tumour Biol       Date:  2013-11-08

3.  MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk.

Authors:  Lidia Maria Rebolho Batista da Silva; Ana Lívia Silva Galbiatti; Mariangela Torreglosa Ruiz; Luiz Sérgio Raposo; José Victor Maniglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2011-06-01       Impact factor: 2.316

Review 4.  Head and neck squamous cell carcinoma in the young: a spectrum or a distinct group? Part 1.

Authors:  M Toner; E M O'Regan
Journal:  Head Neck Pathol       Date:  2009-08-19

5.  Association between IL-4 -590C>T polymorphism and gastric cancer risk.

Authors:  Zihan Sun; Yuling Cui; Xiaohong Jin; Jing Pei
Journal:  Tumour Biol       Date:  2013-09-27

6.  Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility.

Authors:  Zihan Sun; Jing Pei; Fengyun Cui; Yanhua Jing; Chengjin Hu
Journal:  Tumour Biol       Date:  2014-01-26

Review 7.  Current and potential inflammation targeted therapies in head and neck cancer.

Authors:  Frederick Wang; Pattatheyil Arun; Jay Friedman; Zhong Chen; Carter Van Waes
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

Review 8.  Relationship between head and neck cancer therapy and some genetic endpoints.

Authors:  Eliana Maria Minicucci; Glenda Nicioli da Silva; Daisy Maria Fávero Salvadori
Journal:  World J Clin Oncol       Date:  2014-05-10

9.  Association between interleukin-4 -590C > T polymorphism and non-Hodgkin's lymphoma risk.

Authors:  Cuiling Zhou; Shouyong Cui; Rongjiao Zhou; Lianfeng Dou
Journal:  Tumour Biol       Date:  2013-11-23

10.  p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia.

Authors:  Cristina Saiz-Ladera; María Fernanda Lara; Marina Garín; Sergio Ruiz; Mirentxu Santos; Corina Lorz; Ramón García-Escudero; Mónica Martínez-Fernández; Ana Bravo; Oscar Fernández-Capetillo; Carmen Segrelles; Jesús M Paramio
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.